ERBB2 and neoplasm: In the ER+/PgR+/HER2- group, the ER percentage ranged from 10% to 100% (median, 88.5%), and the PgR percentage ranged from 20% to 100% (median, 69.1%); none of the tumours expressed ER in the range of 1% to 9%.